Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...
DexCom stock (NASDAQ: DXCM) currently trades at $73 per share, around 55% below the highs of $163 seen in November 2021. In comparison, Insulet stock (NASDAQ: PODD) saw its stock decline 39% over the ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
DexCom, Inc. reduced its 2024 revenue guidance following a decline in new U.S. customers and revenue per customer, leading to a sharp share price drop, despite $750 million share buyback. DexCom faces ...
LONDON, ENGLAND - JUNE 17: Dexcom Warriors Roxy Horner, Adam Smith and Henry Slade host Puppy Yoga to promote mental wellbeing for Diabetes Awareness Week on June 17, 2023 in London, England. (Photo ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and ...
Dexcom, the San Diego-based maker of continuous glucose monitors, is moving its local manufacturing operations to Arizona and cutting more than 500 local jobs. Barry Regan, Dexcom’s executive vice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results